Skip to main content

Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

Publication ,  Journal Article
Piccini, JP; Hellkamp, AS; Washam, JB; Becker, RC; Breithardt, G; Berkowitz, SD; Halperin, JL; Hankey, GJ; Hacke, W; Mahaffey, KW; Nessel, CC ...
Published in: Circulation
July 12, 2016

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 12, 2016

Volume

134

Issue

2

Start / End Page

e7 / e8

Location

United States

Related Subject Headings

  • Warfarin
  • Stroke
  • Rivaroxaban
  • Polypharmacy
  • Morpholines
  • Humans
  • Factor Xa Inhibitors
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • Anticoagulants
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Hellkamp, A. S., Washam, J. B., Becker, R. C., Breithardt, G., Berkowitz, S. D., … Patel, M. R. (2016). Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Circulation, 134(2), e7–e8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737
Piccini, Jonathan P., Anne S. Hellkamp, Jeffrey B. Washam, Richard C. Becker, Günter Breithardt, Scott D. Berkowitz, Jonathan L. Halperin, et al. “Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".Circulation 134, no. 2 (July 12, 2016): e7–8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737.
Piccini JP, Hellkamp AS, Washam JB, Becker RC, Breithardt G, Berkowitz SD, Halperin JL, Hankey GJ, Hacke W, Mahaffey KW, Nessel CC, Singer DE, Fox KAA, Patel MR. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Circulation. 2016 Jul 12;134(2):e7–e8.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 12, 2016

Volume

134

Issue

2

Start / End Page

e7 / e8

Location

United States

Related Subject Headings

  • Warfarin
  • Stroke
  • Rivaroxaban
  • Polypharmacy
  • Morpholines
  • Humans
  • Factor Xa Inhibitors
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • Anticoagulants